Prostaglandin E2 Reverses Aberrant Production of an Inflammatory Chemokine by Microglia from Sandhoff Disease Model Mice through the cAMP-PKA Pathway Down-Regulation of MIP-1 by PGE2 in SD Microglia
2011

Prostaglandin E2 Reduces Inflammatory Chemokine Production in Sandhoff Disease Model Mice

publication Evidence: moderate

Author Information

Author(s): Kawashita Eri, Tsuji Daisuke, Toyoshima Masahiro, Kanno Yosuke, Matsuno Hiroyuki, Itoh Kohji

Primary Institution: The University of Tokushima

Hypothesis

Can prostaglandin E2 (PGE2) suppress the production of MIP-1α in microglia from Sandhoff disease model mice?

Conclusion

PGE2 acts as a negative regulator of MIP-1α production in microglia from Sandhoff disease model mice.

Supporting Evidence

  • PGE2 reduced MIP-1α production by SD-Mg to the same level as by WT-Mg.
  • PGE2 attenuated the activation of Akt and JNK in microglia.
  • The inhibition of MIP-1α production occurred through the EP2 and 4/cAMP/PKA signaling pathway.

Takeaway

This study shows that a substance called PGE2 can help reduce a harmful protein in brain cells of mice with a disease called Sandhoff disease.

Methodology

The study involved treating microglial cells from Sandhoff disease model mice with PGE2 and measuring the production of MIP-1α and the activation of signaling pathways.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016269

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication